Page last updated: 2024-10-25

deferoxamine and Toxoplasmosis, Animal

deferoxamine has been researched along with Toxoplasmosis, Animal in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Toxoplasmosis, Animal: Acquired infection of non-human animals by organisms of the genus TOXOPLASMA.

Research Excerpts

ExcerptRelevanceReference
" Three doses of 200, 300 and 400 mg/kg DFO were used either alone or in combination with pyrimethamine."1.30Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice. ( Mahmoud, MS, 1999)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mahmoud, MS1

Other Studies

1 other study available for deferoxamine and Toxoplasmosis, Animal

ArticleYear
Effect of deferoxamine alone and combined with pyrimethamine on acute toxoplasmosis in mice.
    Journal of the Egyptian Society of Parasitology, 1999, Volume: 29, Issue:3

    Topics: Acute Disease; Animals; Antiprotozoal Agents; Deferoxamine; Disease Models, Animal; Drug Therapy, Co

1999